Nyxoah S.A. (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
7.02
-0.64 (-8.30%)
Mar 31, 2025, 2:33 PM EDT - Market open
Nyxoah Employees
Nyxoah had 184 employees as of December 31, 2024. The number of employees increased by 37 or 25.07% compared to the previous year.
Employees
184
Change (1Y)
37
Growth (1Y)
25.07%
Revenue / Employee
$25,494
Profits / Employee
-$334,026
Market Cap
262.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NYXH News
- 3 days ago - Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. - Accesswire
- 5 days ago - FDA Issues Nyxoah an Approvable Letter for its Genio® System - GlobeNewsWire
- 17 days ago - Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results - GlobeNewsWire
- 20 days ago - Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 - GlobeNewsWire
- 27 days ago - Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 5 weeks ago - Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewsWire
- 2 months ago - Publication relating to transparency notifications - GlobeNewsWire